BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26626085)

  • 21. The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.
    Carén H; Pollard SM; Beck S
    Mol Aspects Med; 2013; 34(4):849-62. PubMed ID: 22771539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells.
    Lamballe F; Toscano S; Conti F; Arechederra M; Baeza N; Figarella-Branger D; Helmbacher F; Maina F
    Oncotarget; 2016 Nov; 7(46):74747-74767. PubMed ID: 27732969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional control of brain tumor stem cells by a carbohydrate binding protein.
    Sharanek A; Burban A; Hernandez-Corchado A; Madrigal A; Fatakdawala I; Najafabadi HS; Soleimani VD; Jahani-Asl A
    Cell Rep; 2021 Aug; 36(9):109647. PubMed ID: 34469737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.
    Nikolic A; Maule F; Bobyn A; Ellestad K; Paik S; Marhon SA; Mehdipour P; Lun X; Chen HM; Mallard C; Hay AJ; Johnston MJ; Gafuik CJ; Zemp FJ; Shen Y; Ninkovic N; Osz K; Labit E; Berger ND; Brownsey DK; Kelly JJ; Biernaskie J; Dirks PB; Derksen DJ; Jones SJM; Senger DL; Chan JA; Mahoney DJ; De Carvalho DD; Gallo M
    Nat Commun; 2023 May; 14(1):3062. PubMed ID: 37244935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mutations in histone H3.3 and chromatin remodeling genes drive pediatric and young adult glioblastomas].
    Khuong-Quang DA; Gerges N; Jabado N
    Med Sci (Paris); 2012 Oct; 28(10):809-12. PubMed ID: 23067407
    [No Abstract]   [Full Text] [Related]  

  • 27. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
    Jiang Y; Marinescu VD; Xie Y; Jarvius M; Maturi NP; Haglund C; Olofsson S; Lindberg N; Olofsson T; Leijonmarck C; Hesselager G; Alafuzoff I; Fryknäs M; Larsson R; Nelander S; Uhrbom L
    Cell Rep; 2017 Jan; 18(4):977-990. PubMed ID: 28122246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis.
    Harutyunyan AS; Krug B; Chen H; Papillon-Cavanagh S; Zeinieh M; De Jay N; Deshmukh S; Chen CCL; Belle J; Mikael LG; Marchione DM; Li R; Nikbakht H; Hu B; Cagnone G; Cheung WA; Mohammadnia A; Bechet D; Faury D; McConechy MK; Pathania M; Jain SU; Ellezam B; Weil AG; Montpetit A; Salomoni P; Pastinen T; Lu C; Lewis PW; Garcia BA; Kleinman CL; Jabado N; Majewski J
    Nat Commun; 2019 Mar; 10(1):1262. PubMed ID: 30890717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.
    Kwon SM; Kang SH; Park CK; Jung S; Park ES; Lee JS; Kim SH; Woo HG
    PLoS One; 2015; 10(10):e0140528. PubMed ID: 26466313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.
    Schmid RS; Simon JM; Vitucci M; McNeill RS; Bash RE; Werneke AM; Huey L; White KK; Ewend MG; Wu J; Miller CR
    Neuro Oncol; 2016 Jul; 18(7):962-73. PubMed ID: 26826202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
    Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
    Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
    Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
    Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line.
    Toda Y; Yoshimura R; Itahara M; Imai Y; Yamada K; Uno T; Nakata S; Hosogi S; Takata K; Ashihara E
    Anticancer Res; 2019 Nov; 39(11):5983-5990. PubMed ID: 31704823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.
    Voon HPJ; Udugama M; Lin W; Hii L; Law RHP; Steer DL; Das PP; Mann JR; Wong LH
    Nat Commun; 2018 Aug; 9(1):3142. PubMed ID: 30087349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.
    Yin J; Kim SS; Choi E; Oh YT; Lin W; Kim TH; Sa JK; Hong JH; Park SH; Kwon HJ; Jin X; You Y; Kim JH; Kim H; Son J; Lee J; Nam DH; Choi KS; Shi B; Gwak HS; Yoo H; Iavarone A; Kim JH; Park JB
    Nat Commun; 2020 Jun; 11(1):2978. PubMed ID: 32532977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.